Which has stronger earnings and valuation, MDAI or IRIX?

IRIDEX has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Spectral AI $15.39M 3.45 -$7.57M -$0.35 N/A IRIDEX $52.67M 0.30 -$4.44M -$0.20 N/A

Is MDAI or IRIX more profitable?

IRIDEX has a net margin of -6.88% compared to Spectral AI's net margin of -69.27%. Company Net Margins Return on Equity Return on Assets Spectral AI -69.27% N/A -78.56% IRIDEX -6.88% N/A -12.55%

Does the media refer more to MDAI or IRIX?

In the previous week, IRIDEX had 130 more articles in the media than Spectral AI. MarketBeat recorded 133 mentions for IRIDEX and 3 mentions for Spectral AI. IRIDEX's average media sentiment score of 0.84 beat Spectral AI's score of 0.61 indicating that IRIDEX is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Spectral AI 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IRIDEX 1 Very Positive mention(s) 21 Positive mention(s) 20 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, COCH or IRIX?

IRIDEX has higher revenue and earnings than Envoy Medical. IRIDEX is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Envoy Medical $207K 245.31 -$23.76M -$0.76 N/A IRIDEX $52.67M 0.30 -$4.44M -$0.20 N/A

Is COCH or IRIX more profitable?

IRIDEX has a net margin of -6.88% compared to Envoy Medical's net margin of -11,304.83%. Company Net Margins Return on Equity Return on Assets Envoy Medical -11,304.83% N/A -144.13% IRIDEX -6.88% N/A -12.55%

Does the media favor COCH or IRIX?

In the previous week, IRIDEX had 127 more articles in the media than Envoy Medical. MarketBeat recorded 133 mentions for IRIDEX and 6 mentions for Envoy Medical. IRIDEX's average media sentiment score of 0.84 beat Envoy Medical's score of 0.66 indicating that IRIDEX is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envoy Medical 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IRIDEX 1 Very Positive mention(s) 21 Positive mention(s) 20 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to IRIX or SRTS?

In the previous week, IRIDEX had 131 more articles in the media than Sensus Healthcare. MarketBeat recorded 133 mentions for IRIDEX and 2 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 0.91 beat IRIDEX's score of 0.84 indicating that Sensus Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IRIDEX 1 Very Positive mention(s) 21 Positive mention(s) 20 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sensus Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, TELA or IRIX?

IRIDEX has lower revenue, but higher earnings than TELA Bio. IRIDEX is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TELA Bio $80.28M 0.62 -$38.83M -$0.77 N/A IRIDEX $52.67M 0.30 -$4.44M -$0.20 N/A

Is TELA or IRIX more profitable?

IRIDEX has a net margin of -6.88% compared to TELA Bio's net margin of -51.53%. IRIDEX's return on equity of 0.00% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -51.53% -1,320.81% -59.39% IRIDEX -6.88% N/A -12.55%

Does the media favor TELA or IRIX?

In the previous week, IRIDEX had 124 more articles in the media than TELA Bio. MarketBeat recorded 133 mentions for IRIDEX and 9 mentions for TELA Bio. IRIDEX's average media sentiment score of 0.84 beat TELA Bio's score of 0.66 indicating that IRIDEX is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IRIDEX 1 Very Positive mention(s) 21 Positive mention(s) 20 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer IRIX or POCI?

IRIDEX presently has a consensus price target of $3.00, suggesting a potential upside of 237.08%. Given IRIDEX's stronger consensus rating and higher possible upside, analysts plainly believe IRIDEX is more favorable than Precision Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is IRIX or POCI more profitable?

IRIDEX has a net margin of -6.88% compared to Precision Optics' net margin of -11.51%. IRIDEX's return on equity of 0.00% beat Precision Optics' return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.88% N/A -12.55% Precision Optics -11.51% -23.92% -13.05%

Does the media prefer IRIX or POCI?

In the previous week, IRIDEX had 128 more articles in the media than Precision Optics. MarketBeat recorded 133 mentions for IRIDEX and 5 mentions for Precision Optics. IRIDEX's average media sentiment score of 0.84 beat Precision Optics' score of 0.51 indicating that IRIDEX is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IRIDEX 1 Very Positive mention(s) 21 Positive mention(s) 20 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Precision Optics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

IRIDEX (IRIX) Competitors

$0.93 +0.04 (+4.38%)

As of 03:10 PM Eastern

Compare

IRIX vs. MDAI, COCH, SRTS, TELA, and POCI

Should you buy IRIDEX stock or one of its competitors? IRIDEX's main competitors and comparable companies include Spectral AI (MDAI), Envoy Medical (COCH), Sensus Healthcare (SRTS), TELA Bio (TELA), and Precision Optics (POCI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does IRIDEX compare to Spectral AI?

Spectral AI (NASDAQ:MDAI) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

IRIDEX has a net margin of -6.88% compared to Spectral AI's net margin of -69.27%.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-69.27%	N/A	-78.56%
IRIDEX	-6.88%	N/A	-12.55%

In the previous week, IRIDEX had 130 more articles in the media than Spectral AI. MarketBeat recorded 133 mentions for IRIDEX and 3 mentions for Spectral AI. IRIDEX's average media sentiment score of 0.84 beat Spectral AI's score of 0.61 indicating that IRIDEX is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Spectral AI	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IRIDEX	1 Very Positive mention(s)	21 Positive mention(s)	20 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

67.1% of Spectral AI shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 13.7% of Spectral AI shares are held by company insiders. Comparatively, 8.6% of IRIDEX shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

IRIDEX has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$15.39M	3.45	-$7.57M	-$0.35	N/A
IRIDEX	$52.67M	0.30	-$4.44M	-$0.20	N/A

Spectral AI has a beta of 1.21, suggesting that its stock price is 21% more volatile than the broader market. Comparatively, IRIDEX has a beta of 0.67, suggesting that its stock price is 33% less volatile than the broader market.

Spectral AI currently has a consensus price target of $4.00, indicating a potential upside of 142.42%. IRIDEX has a consensus price target of $3.00, indicating a potential upside of 237.08%. Given IRIDEX's higher probable upside, analysts clearly believe IRIDEX is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

IRIDEX beats Spectral AI on 9 of the 15 factors compared between the two stocks.

How does IRIDEX compare to Envoy Medical?

Envoy Medical (NASDAQ:COCH) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings and valuation.

Envoy Medical currently has a consensus price target of $2.17, indicating a potential upside of 229.38%. IRIDEX has a consensus price target of $3.00, indicating a potential upside of 237.08%. Given IRIDEX's higher possible upside, analysts clearly believe IRIDEX is more favorable than Envoy Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

IRIDEX has higher revenue and earnings than Envoy Medical. IRIDEX is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$207K	245.31	-$23.76M	-$0.76	N/A
IRIDEX	$52.67M	0.30	-$4.44M	-$0.20	N/A

Envoy Medical has a beta of 1.97, meaning that its share price is 97% more volatile than the broader market. Comparatively, IRIDEX has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market.

IRIDEX has a net margin of -6.88% compared to Envoy Medical's net margin of -11,304.83%.

Company	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-11,304.83%	N/A	-144.13%
IRIDEX	-6.88%	N/A	-12.55%

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 7.2% of Envoy Medical shares are owned by insiders. Comparatively, 8.6% of IRIDEX shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, IRIDEX had 127 more articles in the media than Envoy Medical. MarketBeat recorded 133 mentions for IRIDEX and 6 mentions for Envoy Medical. IRIDEX's average media sentiment score of 0.84 beat Envoy Medical's score of 0.66 indicating that IRIDEX is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envoy Medical	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IRIDEX	1 Very Positive mention(s)	21 Positive mention(s)	20 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

IRIDEX beats Envoy Medical on 10 of the 15 factors compared between the two stocks.

How does IRIDEX compare to Sensus Healthcare?

IRIDEX (NASDAQ:IRIX) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

In the previous week, IRIDEX had 131 more articles in the media than Sensus Healthcare. MarketBeat recorded 133 mentions for IRIDEX and 2 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 0.91 beat IRIDEX's score of 0.84 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IRIDEX	1 Very Positive mention(s)	21 Positive mention(s)	20 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sensus Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

IRIDEX has higher revenue and earnings than Sensus Healthcare. IRIDEX is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.30	-$4.44M	-$0.20	N/A
Sensus Healthcare	$17.51M	2.77	-$7.72M	-$0.94	N/A

IRIDEX presently has a consensus price target of $3.00, indicating a potential upside of 237.08%. Sensus Healthcare has a consensus price target of $5.83, indicating a potential upside of 97.74%. Given IRIDEX's higher probable upside, equities research analysts clearly believe IRIDEX is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 8.6% of IRIDEX shares are held by company insiders. Comparatively, 10.2% of Sensus Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

IRIDEX has a beta of 0.67, suggesting that its share price is 33% less volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market.

IRIDEX has a net margin of -6.88% compared to Sensus Healthcare's net margin of -88.45%. IRIDEX's return on equity of 0.00% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.88%	N/A	-12.55%
Sensus Healthcare	-88.45%	-21.57%	-19.20%

Summary

IRIDEX and Sensus Healthcare tied by winning 8 of the 16 factors compared between the two stocks.

How does IRIDEX compare to TELA Bio?

TELA Bio (NASDAQ:TELA) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment and dividends.

TELA Bio has a beta of 1.36, indicating that its share price is 36% more volatile than the broader market. Comparatively, IRIDEX has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market.

TELA Bio presently has a consensus target price of $2.14, indicating a potential upside of 93.05%. IRIDEX has a consensus target price of $3.00, indicating a potential upside of 237.08%. Given IRIDEX's higher possible upside, analysts clearly believe IRIDEX is more favorable than TELA Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

IRIDEX has lower revenue, but higher earnings than TELA Bio. IRIDEX is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.28M	0.62	-$38.83M	-$0.77	N/A
IRIDEX	$52.67M	0.30	-$4.44M	-$0.20	N/A

94.4% of TELA Bio shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 1.1% of TELA Bio shares are owned by insiders. Comparatively, 8.6% of IRIDEX shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

IRIDEX has a net margin of -6.88% compared to TELA Bio's net margin of -51.53%. IRIDEX's return on equity of 0.00% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-51.53%	-1,320.81%	-59.39%
IRIDEX	-6.88%	N/A	-12.55%

In the previous week, IRIDEX had 124 more articles in the media than TELA Bio. MarketBeat recorded 133 mentions for IRIDEX and 9 mentions for TELA Bio. IRIDEX's average media sentiment score of 0.84 beat TELA Bio's score of 0.66 indicating that IRIDEX is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TELA Bio	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IRIDEX	1 Very Positive mention(s)	21 Positive mention(s)	20 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

IRIDEX beats TELA Bio on 9 of the 16 factors compared between the two stocks.

How does IRIDEX compare to Precision Optics?

IRIDEX (NASDAQ:IRIX) and Precision Optics (NASDAQ:POCI) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

IRIDEX has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market. Comparatively, Precision Optics has a beta of 0.34, meaning that its share price is 66% less volatile than the broader market.

20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 13.7% of Precision Optics shares are owned by institutional investors. 8.6% of IRIDEX shares are owned by insiders. Comparatively, 14.4% of Precision Optics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Precision Optics has lower revenue, but higher earnings than IRIDEX. Precision Optics is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.30	-$4.44M	-$0.20	N/A
Precision Optics	$31.53M	1.59	-$3.63M	-$0.46	N/A

IRIDEX has a net margin of -6.88% compared to Precision Optics' net margin of -11.51%. IRIDEX's return on equity of 0.00% beat Precision Optics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.88%	N/A	-12.55%
Precision Optics	-11.51%	-23.92%	-13.05%

IRIDEX presently has a consensus price target of $3.00, suggesting a potential upside of 237.08%. Given IRIDEX's stronger consensus rating and higher possible upside, analysts plainly believe IRIDEX is more favorable than Precision Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, IRIDEX had 128 more articles in the media than Precision Optics. MarketBeat recorded 133 mentions for IRIDEX and 5 mentions for Precision Optics. IRIDEX's average media sentiment score of 0.84 beat Precision Optics' score of 0.51 indicating that IRIDEX is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IRIDEX	1 Very Positive mention(s)	21 Positive mention(s)	20 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Precision Optics	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

IRIDEX beats Precision Optics on 13 of the 16 factors compared between the two stocks.

Get IRIDEX News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IRIX vs. The Competition

Export

Metric	IRIDEX	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$16.67M	$5.55B	$7.25B	$13.22B
Dividend Yield	N/A	1.77%	2.53%	22.58%
P/E Ratio	-4.74	25.76	275.62	25.85
Price / Sales	0.32	69.12	580.28	79.50
Price / Cash	N/A	32.56	27.30	36.12
Price / Book	-15.82	5.99	10.84	6.11
Net Income	-$4.44M	$146.14M	$3.50B	$380.72M
7 Day Performance	37.54%	-0.45%	-1.95%	-2.07%
1 Month Performance	43.79%	-2.16%	-4.77%	-3.99%
1 Year Performance	-8.75%	4.23%	6.05%	0.69%

IRIDEX Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IRIX IRIDEX	2.704 of 5 stars	$0.93 +4.4%	$3.00 +222.9%	-14.4%	$16.32M	$52.67M	N/A	108
MDAI Spectral AI	2.0528 of 5 stars	$1.64 -1.2%	$4.00 +143.9%	-26.0%	$52.79M	$19.65M	N/A	65
COCH Envoy Medical	2.9751 of 5 stars	$0.65 +0.4%	$2.17 +231.3%	-25.7%	$50.48M	$240K	N/A	47
SRTS Sensus Healthcare	2.9307 of 5 stars	$2.96 -0.3%	$5.83 +97.1%	-10.1%	$48.72M	$27.48M	N/A	60
TELA TELA Bio	4.3931 of 5 stars	$1.07 -1.8%	$2.14 +100.3%	-24.0%	$48.30M	$80.28M	N/A	218	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IRIX) was last updated on 10/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IRIDEX (IRIX) Competitors

IRIX vs. MDAI, COCH, SRTS, TELA, and POCI

How does IRIDEX compare to Spectral AI?

Summary

How does IRIDEX compare to Envoy Medical?

Summary

How does IRIDEX compare to Sensus Healthcare?

Summary

How does IRIDEX compare to TELA Bio?

Summary

How does IRIDEX compare to Precision Optics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRIX vs. The Competition

IRIDEX Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IRIDEX (IRIX) Competitors

IRIX vs. MDAI, COCH, SRTS, TELA, and POCI

How does IRIDEX compare to Spectral AI?

Is MDAI or IRIX more profitable?

Does the media refer more to MDAI or IRIX?

Do institutionals and insiders have more ownership in MDAI or IRIX?

Which has stronger earnings and valuation, MDAI or IRIX?

Which has more volatility and risk, MDAI or IRIX?

Do analysts recommend MDAI or IRIX?

Summary

How does IRIDEX compare to Envoy Medical?

Do analysts prefer COCH or IRIX?

Which has better earnings & valuation, COCH or IRIX?

Which has more volatility and risk, COCH or IRIX?

Is COCH or IRIX more profitable?

Do institutionals & insiders believe in COCH or IRIX?

Does the media favor COCH or IRIX?

Summary

How does IRIDEX compare to Sensus Healthcare?

Does the media refer more to IRIX or SRTS?

Which has stronger valuation & earnings, IRIX or SRTS?

Do analysts recommend IRIX or SRTS?

Do insiders and institutionals have more ownership in IRIX or SRTS?

Which has more volatility and risk, IRIX or SRTS?

Is IRIX or SRTS more profitable?

Summary

How does IRIDEX compare to TELA Bio?

Which has more volatility & risk, TELA or IRIX?

Do analysts recommend TELA or IRIX?

Which has preferable earnings and valuation, TELA or IRIX?

Do insiders & institutionals believe in TELA or IRIX?

Is TELA or IRIX more profitable?

Does the media favor TELA or IRIX?

Summary

How does IRIDEX compare to Precision Optics?

Which has more volatility and risk, IRIX or POCI?

Do insiders and institutionals hold more shares of IRIX or POCI?

Which has preferable earnings and valuation, IRIX or POCI?

Is IRIX or POCI more profitable?

Do analysts prefer IRIX or POCI?

Does the media prefer IRIX or POCI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRIX vs. The Competition

IRIDEX Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools